0 Σχόλια
0 Μοιράστηκε
2χλμ. Views
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Pegfilgrastim Biosimilar Market, Trends, Covid-19 Impact Analysis, Size And Growth Estimation by Fact MRAs per Fact.MR’s latest industry analysis, the global pegfilgrastim biosimilar market stands at US$ 1.41 billion in 2023. Global demand for pegfilgrastim biosimilars is projected to reach a market valuation of US$ 3.66 billion by 2033-end, increasing at a CAGR of 10% over the next ten years.This substantial growth is driven by the rising incidence of cancer worldwide, increasing adoption...0 Σχόλια 0 Μοιράστηκε 290 Views
-
Biosimilar Market is Projected to Reach USD 185.1 Billion by 2033 | At CAGR 24.1%Overview of the Biosimilar Market: The biosimilar market refers to biologic medical products that are highly similar to already approved reference biologics in terms of safety, purity, and efficacy. Biosimilars are playing a crucial role in expanding access to advanced therapies while reducing healthcare costs. They are widely used in treating chronic diseases such as cancer, autoimmune...0 Σχόλια 0 Μοιράστηκε 102 Views
-
Key Market Drivers for Biosimilar Monoclonal Antibodies Market: Forecast to 2033Biosimilar Monoclonal Antibodies Market Overview Imagine a world where cutting-edge tech transforms industries, boosts efficiency, and opens doors to endless innovation. That's the promise of the market, and according to Straits Research, it's on a rocket ship trajectory with a robust The global biosimilar monoclonal antibodies market size was valued at USD 14.92 Billion in...0 Σχόλια 0 Μοιράστηκε 341 Views
© 2025 Scenario.press - libera espressione
Greek
